US FDA Personnel Costs Drop: Is The Next Generation Taking Over?

 
• By Derrick Gingery

The agency sees its personnel compensation and benefits costs decrease for the first time in at least 16 years, while the overall FTE count continues to rise.

A businessman in blue shirt is holding a magnifying glass in his hand, is searching for personnel or people. Detective looking for missing person crowd of miniature figures choosing most suitable one - Image
Personnel costs for human and generic drug review increased, while personnel costs for biosimilar review decreased, in FY 2019 compared to the previous year. • Source: Shutterstock

More from US FDA

More from Agency Leadership